News | April 14, 2026
New guidance aims to speed up diagnosis of childhood abdominal cancers
Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours
Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
Spread across nearly 4,500 sq. ft., the new clinic combines advanced dental technology, experienced specialists, and an Atithi-first care model
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
Final approval for progesterone vaginal inserts expands Glenmark’s women’s healthcare portfolio in the US, targeting a market of over $59 million
Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust
Subscribe To Our Newsletter & Stay Updated
